EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas

Clinical trial NCT00377936 · COMPLETED

Trial details

NCT number: NCT00377936
Sponsor: MediGene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma Metastasis Pancreas Neoplasms

Start date: 2005-09-01
Primary completion: 2008-06-01
Enrollment: 212

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.